Stock Events

MEDTRONIC 

€72.21
3494
+€0.52+0.73% Friday 12:14

Statistics

Day High
72.21
Day Low
72.21
52W High
84.54
52W Low
67.98
Volume
15
Avg. Volume
50
Mkt Cap
-
P/E Ratio
-
Dividend Yield
3.62%
Dividend
2.61

Upcoming

Dividends

3.62%Dividend Yield
10Y Growth
10.95%
5Y Growth
6.43%
3Y Growth
7.05%
1Y Growth
2.44%

Earnings

23MayConfirmed
Q3 2022
Q4 2022
Q1 2023
Q2 2023
Q3 2023
Q4 2023
Q1 2024
1.02
1.17
1.32
1.46
Expected EPS
1.3407859999999998
Actual EPS
1.3500328

People Also Follow

This list is based on the watchlists of people on Stock Events who follow 1MDT.MI. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Abbott Laboratories
ABT
Mkt Cap180.96B
Abbott Laboratories competes directly with Medtronic in the medical device sector, particularly in cardiovascular and diabetes care products.
Boston Scientific
BSX
Mkt Cap112.32B
Boston Scientific Corporation is a major competitor in the medical devices market, especially in areas like cardiac and vascular products, competing directly with Medtronic's offerings.
Johnson & Johnson
JNJ
Mkt Cap352.53B
Johnson & Johnson, through its medical devices division, competes across several areas including surgical products and orthopaedics, overlapping with Medtronic's product lines.
Smith & Nephew
SNN
Mkt Cap11.72B
Smith & Nephew competes with Medtronic in the orthopedics segment, offering similar products for joint replacement and advanced wound management.
Stryker
SYK
Mkt Cap128.48B
Stryker Corporation is a competitor in the medical technology field, particularly in orthopaedics, neurotechnology, and spine products, which competes with Medtronic's offerings.
Zimmer Biomet
ZBH
Mkt Cap22.22B
Zimmer Biomet Holdings, Inc. competes in the orthopedic product space, offering similar products to Medtronic, particularly in the areas of spine and joint reconstruction.
Edwards Lifesciences
EW
Mkt Cap55.63B
Edwards Lifesciences Corporation specializes in heart valves and hemodynamic monitoring, competing with Medtronic's cardiovascular group.
Baxter International
BAX
Mkt Cap17.79B
Baxter International Inc. competes with Medtronic in the medical devices and hospital products sector, particularly in areas like renal care and advanced surgery.
Intuitive Surgical
ISRG
Mkt Cap157.4B
Intuitive Surgical, Inc. competes in the medical devices sector with its robotic surgical systems, a growing area that poses competition to Medtronic's surgical products.
Hologic
HOLX
Mkt Cap17.29B
Hologic, Inc. competes with Medtronic in the medical imaging and diagnostics field, particularly in women's health, an area where Medtronic also operates.

About

Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. The Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves; and percutaneous coronary intervention products, percutaneous angioplasty balloons, and other products. The Neuroscience Portfolio segment offers medical devices and implants, biologic solutions, spinal cord stimulation and brain modulation systems, implantable drug infusion systems, and interventional products, as well as nerve ablation system under the Accurian name. The segment offers its products for spinal surgeons, neurosurgeons, neurologists, pain management specialists, anesthesiologists, orthopedic surgeons, urologists, urogynecologists, and interventional radiologists, as well as ear, nose, and throat specialists; and energy surgical instruments. The Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure and electrosurgery products, AI-powered surgical video and analytics platform, robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology products, gastrointestinal and hepatologic diagnostics and therapies, and therapies to treat other non-exclusive diseases and conditions; and patient monitoring and airway management products. The Diabetes Operating Unit segment provides insulin pumps and consumables, continuous glucose monitoring systems, and InPen, a smart insulin pen system. The company was founded in 1949 and is headquartered in Dublin, Ireland.
Show more...
CEO
Mr. Geoffrey Straub Martha
Employees
95000
Country
IE
ISIN
IE00BTN1Y115
WKN
000A14M2J

Listings